Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocysticercosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 9, 2007, Pages 970-974

  Fleury, Agnès ^a   Hernandez M ^b   Avila, M ^b   Cardenas G ^a   Bobes, R J ^b   Huerta, M ^c   Fragoso, G ^b   Uribe Campero, L ^d   Harrison, L J S ^e   Parkhouse, R M E ^f   Sciutto, E ^b  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^d Laboratorios Silanes SA de CV   (Mexico)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

HP10 ANTIGEN; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ARTICLE; BLOOD EXAMINATION; BRAIN VENTRICLE; CEREBROSPINAL FLUID EXAMINATION; CONTROLLED STUDY; CYSTICERCOSIS; DECISION MAKING; DISEASE SEVERITY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; IMMUNOASSAY; INTESTINE INFECTION; MAJOR CLINICAL STUDY; NEUROCYSTICERCOSIS; PARASITOSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SUBARACHNOID SPACE;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CEREBRAL VENTRICLES; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; NEUROCYSTICERCOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBARACHNOID SPACE; TAENIA SOLIUM;

EID: 34548184193     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.107243     Document Type: Article

References (20)

1. Sanchez AL, Ljungstrom I, Medina MT. Diagnosis of human neurocysticercosis in endemic countries: a clinical study in Honduras. Parasitol Int 1999;1:81-9.
2. Fleury A, Gomez T, Alvarez I, et al. High prevalence of calcified silent neurocysticercosis in a rural village of Mexico. Neuroepidemiology 2003;22:139-45.
3. Fleury A, Morales J, Bobes RJ, et al. An epidemiological study of familial neurocysticercosis in an endemic Mexican community. Trans R Soc Trop Med Hyg 2006;100:551-8.
4. Fleury A, Dessein A, Preux PM, et al. Symptomatic human neurocysticercosis: age, sex and exposure factors relating with disease heterogeneity. J Neurol 2004;251:830-7.
5. Gongora-Rivera F, Soto-Hernandez JL, Gonzalez Esquivel D, et al. Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis. Neurology 2006;66:436-8.
6. Correa D, Sandoval MA, Harrison LJ, et al. Human neurocysticercosis: comparison of enzyme immunoassay capture techniques based on monoclonal and polyclonal antibodies for the detection of parasite products in cerebrospinal fluid. Trans R Soc Trop Med Hyg 1989;83:814-16.
7. Tsang VC, Brand JA, Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 1989;159:50-9.
8. Ramos-Kuri M, Montoya RM, Padilla A, et al. Immunodiagnosis of neurocysticercosis. Disappointing performance of serology (enzyme-linked immunosorbent assay) in an unbiased sample of neurological patients. Arch Neurol 1992;49:633-6.
9. Larralde C, Sotelo J, Montoya RM, et al. Immunodiagnosis of human cysticercosis in cerebrospinal fluid. Antigens from murine Taenia crassiceps cysticerci effectively substitute those from porcine Taenia solium. Arch Pathol Lab Med 1990;114:926-8.
10. Harrison LJ, Joshua GW, Wright SH, et al. Specific detection of circulating surface/secreted glycoproteins of viable cysticerci in Taenia saginata cysticercosis. Parasite Immunol 1989;11:351-70.
11. Harrison LJ, Garate T, Bryce DM, et al. Ag-ELISA and PCR for monitoring the vaccination of cattle against Taenia saginata cysticercosis using an oncospheral adhesion protein (HP6) with surface and secreted localization. Trop Anim Health Prod 2005;37:103-20.
12. Sciutto E, Hernandez M, Garcia G, et al. Diagnosis of porcine cysticercosis: a comparative study of serological tests for detection of circulating antibody and viable parasites. Vet Parasitol 1998;78:185-94.
13. Garcia HH, Gonzalez AE, Gilman RH, et al. Circulating parasite antigen in patients with hydrocephalus secondary to neurocysticercosis. Am J Trop Med Hyg 2002;66:427-30.
14. Garcia HH, Harrison LJ, Parkhouse RM, et al. A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg 1998;92:411-14.
15. Garcia HH, Parkhouse RM, Gilman RH, et al. Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients. Trans R Soc Trop Med Hyg 2000;94:673-6.
16. Fleury A, Hernandez M, Fragoso G, et al. Detection of secreted cysticercal antigen: a useful tool in the diagnosis of inflammatory neurocysticercosis. Trans R Soc Trop Med Hyg 2003;97:542-6.
17. Bernard PM, Lapointe C. Mesures d'accord. In: Mesures statistiques en épidémiologie. Sainte-Foy, Québec: Presses de l'Université du Québec, 1995:131-43.
18. Bobes RJ, Hernández M, Márquez C, et al. Subarachnoidal and intraventricular human neurocysticercosis: application of an antigen detection assay for the diagnosis and follow-up. Trop Med Int Health 2006;11:943-50.
19. Bustos JA, Garcia HH, Dorregaray R, et al. Detection of muscle calcifications by thigh CT scan in neurocysticercosis patients. Trans R Soc Trop Med Hyg 2005;99:775-9.
20. Cruz I, Cruz ME, Teran W, et al. Human subcutaneous Taenia solium cysticercosis in an Andean population with neurocysticercosis. Am J Trop Med Hyg 1994;51:405-7.